(Q41554131)

3 October 2017

1 reference

title

The validity of melatonin as an oncostatic agent (English)

1 reference

3 October 2017

Panzer A

1

1 reference

3 October 2017

Viljoen M

series ordinal

2

1 reference

3 October 2017

language of work or name

1 reference

1 May 1997

1 reference

Journal of Pineal Research

3 October 2017

number of pages

19

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 October 2017

volume

22

1 reference

3 October 2017

issue

4

1 reference

3 October 2017

page(s)

184-202

1 reference

Melatonin stimulates brain glutathione peroxidase activity.

3 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Calmodulin mediates melatonin cytoskeletal effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Melatonin's inhibitory effect on growth of ME-180 human cervical cancer cells is not related to intracellular glutathione concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Effects of the pineal hormone melatonin on the anchorage-independent growth of human breast cancer cells (MCF-7) in a clonogenic culture system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Nitric oxide and oxygen radicals: a question of balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Melatonin receptors: are there multiple subtypes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Melatonin biosynthesis and metabolism in peripheral blood mononuclear leucocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

21 January 2018

Melatonin comes of age?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Seasonal changes in serum melatonin in women with previous breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Melatonin influences Fos expression in the rat suprachiasmatic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Melatonin blocks the stimulatory effects of prolactin on human breast cancer cell growth in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Biological and clinical results of a neuroimmunotherapy with interleukin-2 and the pineal hormone melatonin as a first line treatment in advanced non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

A randomized study of neuroimmunotherapy with low-dose subcutaneous interleukin-2 plus melatonin compared to supportive care alone in patients with untreatable metastatic solid tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Beta-endorphin and dynorphin mimic the circadian immunoenhancing and anti-stress effects of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Melatonin: perspectives in laboratory medicine and clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Melatonin receptors: localization, molecular pharmacology and physiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Communications among central nervous system, neuroendocrine and immune systems: interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

DNA base modifications in chromatin of human cancerous tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

TOR: a new orphan receptor expressed in the thymus that can modulate retinoid and thyroid hormone signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Steroid hormone receptors in the thymus: A site of immunomodulatory action of melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Melatonin: a peroxyl radical scavenger more effective than vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Melatonin increases antigen presentation and amplifies specific and non specific signals for T-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Elevation of intracellular glutathione content associated with mitogenic stimulation of quiescent fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Growth inhibitory and cytotoxic effects of melatonin and its metabolites on human tumour cell lines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Melatonin enhances junctional transfer in normal C3H/10T1/2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

Transport of Albumin-bound Melatonin Through the Blood-Brain Barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-079X.1997.TB00322.X

10.1111/J.1600-079X.1997.TB00322.X

21 January 2018

Identifiers

DOI

1 reference

3 October 2017

1 reference